Adding to the string of US and international drugmakers investment in US production investment following a call from ...

AstraZeneca (NASDAQ: AZN) revealed on Monday its intention to invest $50 billion by 2030 to bolster its manufacturing and ...

Subjects in the trial received 80mg of Tagrisso daily in oral tablet form, combined with a chemotherapy regimen.